148 related articles for article (PubMed ID: 26356731)
21. Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreas.
Kamp K; Damhuis RA; Feelders RA; de Herder WW
Endocr Relat Cancer; 2012 Feb; 19(1):95-9. PubMed ID: 22194442
[TBL] [Abstract][Full Text] [Related]
22. Impacts of family history and lifestyle habits on colorectal cancer risk: a case-control study in Qatar.
Bener A; Moore MA; Ali R; El Ayoubi HR
Asian Pac J Cancer Prev; 2010; 11(4):963-8. PubMed ID: 21133608
[TBL] [Abstract][Full Text] [Related]
23. Associations of Tobacco and Alcohol Use with Risk of Neuroendocrine Tumors of the Small Intestine in Utah.
Curtin K; Cannon-Albright LA; VanDerslice J; Yu Z; Herget KA; Thota R; Neklason DW
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):1998-2004. PubMed ID: 31558509
[TBL] [Abstract][Full Text] [Related]
24. Thyroid dysfunction, thyroid hormone replacement and colorectal cancer risk.
Boursi B; Haynes K; Mamtani R; Yang YX
J Natl Cancer Inst; 2015 Jun; 107(6):djv084. PubMed ID: 25855726
[TBL] [Abstract][Full Text] [Related]
25. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy.
Brenner H; Chang-Claude J; Jansen L; Knebel P; Stock C; Hoffmeister M
Gastroenterology; 2014 Mar; 146(3):709-17. PubMed ID: 24012982
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study.
Capurso G; Boccia S; Salvia R; Del Chiaro M; Frulloni L; Arcidiacono PG; Zerbi A; Manta R; Fabbri C; Ventrucci M; Tarantino I; Piciucchi M; Carnuccio A; Boggi U; Leoncini E; Costamagna G; Delle Fave G; Pezzilli R; Bassi C; Larghi A; ;
Am J Gastroenterol; 2013 Jun; 108(6):1003-9. PubMed ID: 23458848
[TBL] [Abstract][Full Text] [Related]
27. Frequent Use of Antibiotics Is Associated with Colorectal Cancer Risk: Results of a Nested Case-Control Study.
Dik VK; van Oijen MG; Smeets HM; Siersema PD
Dig Dis Sci; 2016 Jan; 61(1):255-64. PubMed ID: 26289256
[TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphisms in XRCC1 genes and colorectal cancer susceptibility.
Huang Y; Li X; He J; Chen L; Huang H; Liang M; Zhu Q; Huang Y; Wang L; Pan C; Xia T
World J Surg Oncol; 2015 Aug; 13():244. PubMed ID: 26271249
[TBL] [Abstract][Full Text] [Related]
29. Consumption of cigarettes but not betel quid or alcohol increases colorectal cancer risk.
Wu IC; Lee CH; Kuo CH; Kuo FC; Wu DC; Ko YC; Yu FJ
J Formos Med Assoc; 2009 Feb; 108(2):155-63. PubMed ID: 19251551
[TBL] [Abstract][Full Text] [Related]
30. Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.
Modlin IM; Gustafsson BI; Drozdov I; Nadler B; Pfragner R; Kidd M
Ann Surg Oncol; 2009 Feb; 16(2):487-98. PubMed ID: 19050963
[TBL] [Abstract][Full Text] [Related]
31. Moderate alcohol consumption protects against colorectal adenomas in smokers.
Austin GL; Galanko JA; Martin CF; Sandler RS
Dig Dis Sci; 2008 Jan; 53(1):116-22. PubMed ID: 17510802
[TBL] [Abstract][Full Text] [Related]
32. Cigarette smoking and colorectal cancer risk in Germany: a population-based case-control study.
Verla-Tebit E; Lilla C; Hoffmeister M; Brenner H; Chang-Claude J
Int J Cancer; 2006 Aug; 119(3):630-5. PubMed ID: 16496385
[TBL] [Abstract][Full Text] [Related]
33. Familial small-intestine carcinoids: Chromosomal alterations and germline inositol polyphosphate multikinase sequencing.
de Mestier L; Pasmant E; Fleury C; Brixi H; Sohier P; Féron T; Diebold MD; Clauser E; Cadiot G;
Dig Liver Dis; 2017 Jan; 49(1):98-102. PubMed ID: 27825921
[TBL] [Abstract][Full Text] [Related]
34. Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer: results from the Netherlands Cohort Study.
Weijenberg MP; Aardening PW; de Kok TM; de Goeij AF; van den Brandt PA
Mutat Res; 2008 Mar; 652(1):54-64. PubMed ID: 18296105
[TBL] [Abstract][Full Text] [Related]
35. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress.
Modlin IM; Champaneria MC; Chan AK; Kidd M
Am J Gastroenterol; 2007 Jul; 102(7):1464-73. PubMed ID: 17391319
[TBL] [Abstract][Full Text] [Related]
36.
Daskalakis K; Norlén O; Karakatsanis A; Hellman P; Larsson R; Nygren P; Stålberg P
Endocr Relat Cancer; 2018 Apr; 25(4):471-480. PubMed ID: 29440231
[TBL] [Abstract][Full Text] [Related]
37. Smoking, lower gastrointestinal endoscopy, and risk for colorectal cancer.
Hoffmeister M; Jansen L; Stock C; Chang-Claude J; Brenner H
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):525-33. PubMed ID: 24403529
[TBL] [Abstract][Full Text] [Related]
38. Second primary malignancies in patients with neuroendocrine tumors.
Reina JJ; Serrano R; Codes M; Jiménez E; Bolaños M; Gonzalez E; Sevilla I
Clin Transl Oncol; 2014 Oct; 16(10):921-6. PubMed ID: 24788817
[TBL] [Abstract][Full Text] [Related]
39. Health-Related Quality of Life in Patients with Small Intestine Neuroendocrine Tumors.
Karppinen N; Lindén R; Sintonen H; Tarkkanen M; Roine R; Heiskanen I; Matikainen N; Schalin-Jäntti C
Neuroendocrinology; 2018; 107(4):366-374. PubMed ID: 30293074
[TBL] [Abstract][Full Text] [Related]
40. Family history and lung cancer risk: international multicentre case-control study in Eastern and Central Europe and meta-analyses.
Lissowska J; Foretova L; Dabek J; Zaridze D; Szeszenia-Dabrowska N; Rudnai P; Fabianova E; Cassidy A; Mates D; Bencko V; Janout V; Hung RJ; Brennan P; Boffetta P
Cancer Causes Control; 2010 Jul; 21(7):1091-104. PubMed ID: 20306329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
